|
文献名
|
提交时间
|
查询结果
|
回复时间
|
|
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy
|
2019-02-17 19:04:28
|
已发送至邮箱
|
2019-02-18 17:54:42
|
|
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
|
2019-02-17 19:01:27
|
已发送至邮箱
|
2019-02-18 17:55:33
|
|
Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme
|
2019-02-17 17:56:02
|
已发送至邮箱
|
2019-02-18 17:59:04
|
|
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials
|
2019-02-17 17:36:59
|
已发送至邮箱
|
2019-02-19 17:22:55
|
|
Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study
|
2019-02-17 17:34:46
|
已发送至邮箱
|
2019-02-18 18:22:19
|
|
Treatment of advanced non-small cell lung cancer in the elderly
|
2019-02-17 17:31:10
|
已发送至邮箱
|
2019-02-18 18:30:38
|
|
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer
|
2019-02-17 17:29:32
|
已发送至邮箱
|
2019-02-18 18:22:38
|
|
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors
|
2019-02-17 17:28:01
|
已发送至邮箱
|
2019-02-18 18:22:54
|
|
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
|
2019-02-16 17:30:27
|
已发送至邮箱
|
2019-02-18 18:23:11
|
|
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations
|
2019-02-16 17:24:16
|
已发送至邮箱
|
2019-02-18 18:08:46
|